Bioassay for reverse transcriptase inhibitors

Details Bioassay for reverse transcriptase inhibitors Bioassay for reverse transcriptase inhibitors

1994-03-09

1996-11-19

Jones, W. Gary

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving virus or bacteriophage

435 6, 435 9151, 435183, 435194, 436 63, C12Q 170, C12Q 168, G01N 3348

Patent

active

055761771

ABSTRACT:
The present invention relates generally to methods and kits for determining the bodily level of a reverse transcriptase inhibitor or, therapeutic compound or metabolite thereof used to treat retrovirus infection, particularly HIV 1 infection.

REFERENCES:
patent: 5183949 (1993-02-01), Kindt et al.
Izuta et al., "The 5'-triphosphates of 3'-azido-3'-deoxythymidine and 2',3'-dideoxynucleosides Inhibit DNA Polymerase .gamma. by Different Mechanisms," Biochem. and Biophys. Res. Comm. 179(2):776-783 (1991).
Robbins et al, Antimicrobial Agent & Chemotherapy (Jan. 1994) 38:115-121.
Slusher et al, Antimicrobial Agents & Chemotherapy (Nov. 1992) 36:2473-2477.
Robbins et al, J. Cellular Biochem (Apr. 1993), p. 22, Abstract Q145.
Konig et al, J. Cellular Biochem (1992) p. 36, Abstract Q222.
O'Brien et al, Life Sciences (1993) 52:243-249.
Kuster et al., "A Method for the Quantification of Intracellular Zidovudine Nucleotides," J. of Infectious Diseases 164:773-776 (1991).
Lacey et al., "Biochemical Studies on the Reverse Transcriptase and RNase H Activities from Human Immunodeficiency Virus Strains Resistant to 3'-Azido-3'-deoxythymidine," Biochem. of HIV AZT Resistance 267(22):15789-15794 (1992).
Lambert et al., "2',3'-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related Complex," NEJM 322(19):1333-1340 (1990).
Ma et al., "New Thymidine Triphosphate Analogue Inhibitors of Human Immunodeficiency Virus-1 Reverse Transcriptase," J. Med. Chem. 35:1938-1941 (1992).
Masood et al., "Cellular Pharmacology of the Anti-HIV Agent 2',3'-Didehydro-2',3'-dideoxythymidine" Proc. of the Amer. Assoc. Cancer Research 30:594 abstract A2364 (1989).
Meng et al., "AIDS Clinical Trials Group: Phase I/II Study of Combination 2',3'-Dideoxycytidine and Zidovudine in Patients with Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS-Related Complex," The Amer. J. of Medicine 88 (suppl 5B):27S-30S (1990).
Mitsuya et al., "3'-Azido-3'-deoxythymidine (BW A509U): An Antiviral Agent That Inhibits the Infectivity and Cytopathic Effect of Human T-lymphotropic Virus Type III/lymphadenopathy-associated Virus In Vitro," Proc. Natl. Acad. Sci. USA 82:7096-7100 (1985).
Olsen et al., "Interaction of HIV1-RT With Azidothymidine Triphosphate and the Nonnucleoside Inhibitor L-697, 661," Int. Conf. AIDS 7(2):A45 abstract PoA 2255 (1992).
Parker et al., "Inhibition of Human DNA Polymerases and Human Immunodeficiency Virus (HIV) Reverse Transcriptase by a Novel Class of Compounds, Galloylquinic Acids," Proc. of the Amer. Assoc. for Cancer Res. 30:578 abstract 2301 (1989).
Parker et al., "Mechanism of Inhibition of Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Human DNA Polymerases .alpha., .beta., and .gamma. by the 5'-Triphosphates of Carbovir, 3'-Azido-3'-deoxythymidine, 2',3'-Dideoxyguanosine, and 3'-Deoxythymidine," J. Biol. Chem. 266(3):1754-1762 (1991).
Pei-zhen et al., "An in vitro EIAV RT Model for Screening of Anti-HIV Agents", Intl. Conf. AIDS 5:501 abstract B.626 (1989).
Reardon, J. E., "Human Immunodeficiency Virus Reverse Transcriptase; Steady-State and Pre-Steady-State Kinetics of Nucleotide Incorporation," Biochem. 31(18):4473-4479 (1992).
Robbins et al., "A Novel Method for the Measurement of Intracellular Zidovudine Triphosphate (ZDV-TP)," J. Cellular Biochem. Supp 17E:22 abstract Q145 (1993).
Shirasaka et al., "In Vitro Study of Drug-Sensitivity of HIV Strains Isolated from Patients with AIDS or ARC Before and After Therapy with AZT and/or 2',3'-Dideoxycytidine (ddC)," Intl. Conf. AIDS 6(1):185 abstract Th.A.263 (1990).
Skowron, et al., "Alternating and Intermittent Regimens of Zidovudine and Dideoxycytidine in Patients with AIDS or AIDS-Related Complex," Annals of Int. Medicine 118(5):321-330 (1993).
Slusher et al., "Intracellular Zidovudine (ZDV) and ZDV Phosphates as Measured by a Validated Combined High-Pressure Liquid Chromatography-Radioimmunoassay Procedure," Antimicrobial Agents and Chemotherapy 36(11):2473-2477 (1992).
Tavares et al., "3'-Azido-3'-deoxythymidine in Feline Leukemia Virus-infected Cats: A Model for Therapy and Prophylaxis of AIDS," Cancer Research 47:3190-3194 (1987).
Toyoshima et al., "A Sensitive Nonisotopic Method for the Determination of Intracellular Azidothymidine 5'-Mono-,5'-Di-; and 5'-Triphosphate," Analytical Biochemistry 196:302-307 (1991).
Vogt et al., "Experimental Azidothymidine (AZT) Pulse Therapy Leads to Adequate and Prolonged Levels of Intracellular AZT-Triphosphate (AZT-TP)," Intl. Conf. AIDS 5:555 abstract M.C.P.83 (1989).
Vrang et al., "Inhibition of the Reverse Transcriptase from HIV by 3'-azido-3'-deoxythymidine Triphosphate and its threo Analogue," Antiviral Research 7:139-149 (1987).
Wainberg et al., "Characterization of AZT-Resistant Isolates of HIV-1: Susceptibility to Deoxythiacytidine and Other Nucleosides," Intl. Conf. AIDS 6(3):117 abstract S.B.87 (1990).
White et al., "Mechanism of Inhibition by Carbovir Triphosphate of HIV Reverse Transcriptase and Human DNA Polymerases, Compared with the Action of AZT Triphosphate and Dideoxynucleoside Triphosphates," Intl. Conf. AIDS 6(1):186 abstract Th.A.266 (1990).
White et al., "A TIBO Derivative, R82913, is a Potent Inhibitor of HIV-1 Reverse Transcriptase with Heteropolymer Templates," Antiviral Research 16:257-266 (1991).
Yarchoan et al., "Administration of 3'-Azido-3'-Deoxythymidine, An Inhibitor of HTLV-III/LAV Replication, to Patients with AIDS or AIDS-Related Complex," Lancet pp. 575-580 (1986).
Balzarini et al., "Differential Patterns of Intracellular Metabolism of 2',3'-Didehydro-2',3'-dideoxythymidine and 3'-Azido-2',3'-dideoxythymidine, Two Potent Anti-Human Immunodeficiency Virus Compounds," J. Biol. Chem. 264(11):6127-6133 (1989).
Boucher et al., "Phase I Evaluation of Zidovudine Administered to Infants Exposed at Birth to the Human Immunodeficiency Virus," Journal of Pediatrics 122(1):137-144 (1993).
Butler, W. B., "Preparing Nuclei from Cells in Monolayer Cultures Suitable for Counting and for Following Synchronized Cells through the Cell Cycle," Analytical Biochemistry 141:70-73 (1984).
Fischl et al., "The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex," NEJM 317(4):185-191 (1987).
Fischl et al., "A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome," NEJM 323(15):1009-1014 (1990).
Fletcher et al., "Comparative Pharmacokinetics of Zidovudine in Healthy Volunteers and in Patients With AIDS With and Without Hepatic Disease," Pharmacotherapy 12(6):429-434 (1992).
Furman et al., "Phosphorylation of 3'-azido-3'-deoxythymidine and Selective Interaction of the 5'-triphosphate with Human Immunodeficiency Virus Reverse Transcriptase" Proc. Natl. Acad. Sci. USA 83:8333-8337 (1986).
Furman et al., "Spectrum of Antiviral Activity and Mechanism of Action of Zidovudine," The American Journal of Medicine 85(Supp 2A):176-181 (1988).
Hovanessian et al., "Antiviral Activity of Poly(A).Poly(U) Against HIV in vitro," Intl. Conf. AIDS 7(2):113 abstract W.A.1084 (1991).

Affiliated with

Also associated with

Rating

Bioassay for reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioassay for reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioassay for reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-540120